Additionally, a longitudinal study in two independent Chinese cohorts demonstrated that the plasma levels of Aβ42, p-tau181, and neurofilament light chain (NfL) were significantly altered up to eight years before clinical onset, supporting their utility for identifying preclinical AD [89]. Here, NEFL is linked to Alzheimer disease.